Mehta K - Search Results

1

Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.

Verma A, Guha S, Diagaradjane P, Kunnumakkara AB, Sanguino AM, Lopez-Berestein G, Sood AK, Aggarwal BB, Krishnan S, Gelovani JG, Mehta K. Verma A, et al. Among authors: mehta k. Clin Cancer Res. 2008 Apr 15;14(8):2476-83. doi: 10.1158/1078-0432.CCR-07-4529. Clin Cancer Res. 2008. PMID: 18413840

2

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway.

Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K. Mann AP, et al. Among authors: mehta k. Cancer Res. 2006 Sep 1;66(17):8788-95. doi: 10.1158/0008-5472.CAN-06-1457. Cancer Res. 2006. PMID: 16951195

3

Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis.

Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K. Verma A, et al. Among authors: mehta k. Cancer Res. 2006 Nov 1;66(21):10525-33. doi: 10.1158/0008-5472.CAN-06-2387. Cancer Res. 2006. PMID: 17079475

4

Tissue transglutaminase inhibits autophagy in pancreatic cancer cells.

Akar U, Ozpolat B, Mehta K, Fok J, Kondo Y, Lopez-Berestein G. Akar U, et al. Among authors: mehta k. Mol Cancer Res. 2007 Mar;5(3):241-9. doi: 10.1158/1541-7786.MCR-06-0229. Mol Cancer Res. 2007. PMID: 17374730

5

PKC delta and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells.

Ozpolat B, Akar U, Mehta K, Lopez-Berestein G. Ozpolat B, et al. Among authors: mehta k. Autophagy. 2007 Sep-Oct;3(5):480-3. doi: 10.4161/auto.4349. Epub 2007 Apr 27. Autophagy. 2007. PMID: 17507797

6

Tissue transglutaminase-mediated chemoresistance in cancer cells.

Verma A, Mehta K. Verma A, et al. Among authors: mehta k. Drug Resist Updat. 2007 Aug-Oct;10(4-5):144-51. doi: 10.1016/j.drup.2007.06.002. Epub 2007 Jul 27. Drug Resist Updat. 2007. PMID: 17662645 Review.

7

Transglutaminase-mediated activation of nuclear transcription factor-kappaB in cancer cells: a new therapeutic opportunity.

Verma A, Mehta K. Verma A, et al. Among authors: mehta k. Curr Cancer Drug Targets. 2007 Sep;7(6):559-65. doi: 10.2174/156800907781662275. Curr Cancer Drug Targets. 2007. PMID: 17896921 Review.

8

Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.

Verma A, Guha S, Wang H, Fok JY, Koul D, Abbruzzese J, Mehta K. Verma A, et al. Among authors: mehta k. Clin Cancer Res. 2008 Apr 1;14(7):1997-2005. doi: 10.1158/1078-0432.CCR-07-1533. Clin Cancer Res. 2008. PMID: 18381937

9

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.

Hwang JY, Mangala LS, Fok JY, Lin YG, Merritt WM, Spannuth WA, Nick AM, Fiterman DJ, Vivas-Mejia PE, Deavers MT, Coleman RL, Lopez-Berestein G, Mehta K, Sood AK. Hwang JY, et al. Among authors: mehta k. Cancer Res. 2008 Jul 15;68(14):5849-58. doi: 10.1158/0008-5472.CAN-07-6130. Cancer Res. 2008. PMID: 18632639 Free PMC article.

10

Tissue transglutaminase promotes or suppresses tumors depending on cell context.

Chhabra A, Verma A, Mehta K. Chhabra A, et al. Among authors: mehta k. Anticancer Res. 2009 Jun;29(6):1909-19. Anticancer Res. 2009. PMID: 19528447 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,426 results

Search Page

Filters